Compound F08060425 affects key pathways like cytokine signaling and the Adaptive immune system, interacting with genes FLT3, SYK, and ROCK1, indicating its role in immune modulation and potential applications in cancer therapy. The gene discussed is FLT3; the disease is cancer.